A tool for managing stress and improving quality of life in cancer patients
My Wellbeing Guide, Technology Facilitated Behavioral Intervention for Depression Among Diverse Patients in Ambulatory Oncology
This study is testing an online program called My Wellbeing Guide to see if it can help cancer patients feel less depressed and improve their quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 6516 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Northwestern University Academic / other |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT05369429 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of My Wellbeing Guide, a psychosocial eHealth intervention designed to reduce depressive symptoms in cancer patients. The intervention employs cognitive behavioral therapy strategies delivered through an online application over a 7-week period, featuring animated videos, interactive activities, and written content. Participants will be randomized into either the intervention or a control group, with assessments conducted at baseline, post-intervention, and at 6- and 12-month follow-ups. The study aims to address the high prevalence of depression among cancer patients and improve their overall quality of life.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with a confirmed diagnosis of cancer and elevated depressive symptoms.
Not a fit: Patients without internet access or those who do not meet the eligibility criteria will not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce depressive symptoms and enhance the quality of life for cancer patients.
How similar studies have performed: Other studies have shown success with similar eHealth interventions for managing depression in various populations, indicating potential for this approach in oncology.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: a) having been reached out to by the study team for recruitment; (b) planned treatment and follow-up within the NM or UHealth healthcare system; (c) ≥ 18 years of age; (d) medical chart confirmed diagnosis of a solid or hematological malignancy; (e) elevated depressive symptoms on the PROMIS CAT (score \> or = 55) within the last 3 months; (f) access to the internet; (g) willingness to be randomized; (h) able to read English or Spanish; (i) patients must have signed informed consent prior to registration on study Exclusion Criteria: Note: The investigators will not include any vulnerable populations in this study.
Where this trial is running
Chicago, Illinois
- Northwestern University — Chicago, Illinois, United States (Recruiting)
Study contacts
- Principal investigator: Betina Yanez, PhD — Northwestern University
- Study coordinator: Ro Mercer, BS
- Email: ro.mercer@northwestern.edu
- Phone: 312-503-3943
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.